GO:1903136 cuprous ion binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903136 cuprous ion binding is a molecular function defined as binding to a cuprous ion, copper(1+), also called Cu(I) binding.
• Cuprous ion binding is central to copper homeostasis, copper trafficking, and redox chemistry in proteins such as cupredoxins and multicopper oxidases.
• The CsoR regulon in Streptomyces lividans illustrates how Cu(I) binding controls gene expression for copper efflux and resistance.
• Bicinchoninic acid (BCA) assays exploit competitive Cu(I) binding between protein and BCA, making Cu(I) coordination directly relevant to protein quantification.
• Cuprous ion transfer from copper complexes to cellular proteins has been documented, linking Cu(I) binding to metallodrug action and cellular copper handling.
• Structural studies of dimeric periplasmic proteins and calixarene-based models reveal diverse Cu(I) coordination geometries relevant to biological copper recognition.
Description
Cuprous ion binding (GO:1903136) is a molecular function that describes the non-covalent or coordinate binding of a copper(1+) ion, Cu(I), to a biomolecule. Copper is an essential trace element that cycles between the oxidized cupric form, Cu(II), and the reduced cuprous form, Cu(I), and this redox flexibility underlies its roles in electron transfer, oxygen chemistry, and metalloregulation. Because Cu(I) is a soft, thiophilic metal ion, proteins that bind it often use cysteine, methionine, and histidine residues to form stable coordination environments. Understanding cuprous ion binding is therefore fundamental to copper homeostasis, copper-dependent enzyme function, and the mechanisms of copper-responsive transcription factors. Researchers study cuprous ion binding to define how cells acquire, distribute, and detoxify copper, and to explain how perturbations in these processes contribute to disease. The term is also practically important in biochemistry: colorimetric protein assays such as the bicinchoninic acid (BCA) assay depend on competition between protein and BCA for Cu(I), so the binding properties of Cu(I) directly affect measurements. In addition, cuprous ion transfer from copper complexes to cellular proteins has been observed for bleomycin, a metallodrug whose copper complex can be reduced intracellularly and transfer Cu(I) to a cellular protein. These examples show that GO:1903136 is not an abstract annotation but a functional property with experimental and biomedical consequences. This article summarizes the authoritative definition of GO:1903136, the biological and molecular contexts in which cuprous ion binding occurs, the genes and proteins most relevant to this function, and the experimental methods and CRISPR models used to study it. All statements are based on the verified literature cited by number.
cuprous ion binding At A Glance
| GO ID | GO:1903136 |
|---|---|
| GO term | cuprous ion binding |
| Ontology | molecular_function |
| Synonym | copper(1+) binding; Cu(+) binding; Cu(I) binding |
| Definition | Binding to a cuprous ion, copper(1+). |
| Major function | Coordination of Cu(I) by proteins and other biomolecules, enabling copper trafficking, redox chemistry, and metalloregulation. |
| Representative proteins | Cupredoxins, multicopper oxidases, CsoR-family regulators, periplasmic copper-binding proteins. |
| Related processes | Copper homeostasis, copper efflux, electron transfer, protein quantification assays. |
| Experimental readouts | Cu(I) binding assays, BCA competition, spectroscopy, structural biology, transcriptional reporters. |
What Is GO:1903136?
GO:1903136 cuprous ion binding is defined by the Gene Ontology as binding to a cuprous ion, copper(1+). In other words, it is the molecular function of selectively interacting with Cu(I), the reduced form of copper, through coordination or non-covalent interactions. Synonyms include copper(1+) binding, Cu(+) binding, and Cu(I) binding. This term describes the binding event itself rather than downstream catalytic or transport processes, although Cu(I) binding often enables electron transfer, metal transfer, or allosteric regulation in copper-responsive proteins.
Why Is cuprous ion binding Important in Cell Biology?
Cuprous ion binding is important because Cu(I) is the form of copper that participates in key biological processes such as electron transfer and copper trafficking, and because proteins that bind Cu(I) control cellular copper homeostasis. The CsoR regulon in Streptomyces lividans demonstrates that Cu(I) binding by a regulator directly controls expression of copper efflux systems, linking a single binding event to a global resistance response. In biochemistry, Cu(I) binding underlies the BCA protein assay, one of the most widely used methods for protein quantification, through competition between protein and BCA for cuprous ions. Cu(I) binding also mediates the cellular handling of copper-containing drugs and complexes, as shown by the intracellular reduction of the bleomycin copper complex and transfer of Cu(I) to a cellular protein. Thus, GO:1903136 connects molecular coordination chemistry to cell biology, pharmacology, and laboratory practice.
• Cu(I) binding is essential for copper homeostasis and prevents toxic accumulation of free copper.
• CsoR-family regulators use Cu(I) binding to sense copper and activate efflux genes.
• Cupredoxins and multicopper proteins depend on Cu(I) coordination for electron transfer and oxidation reactions.
• The BCA protein assay relies on competitive Cu(I) binding, making this function relevant to routine laboratory measurements.
• Cu(I) transfer from metallodrugs such as bleomycin copper complex to cellular proteins links Cu(I) binding to drug action.
• Structural studies of Cu(I)-binding proteins inform the design of copper-selective sensors and chelators.
• Dysregulation of copper-binding proteins is associated with metabolic and neurodegenerative conditions, motivating research into Cu(I) coordination.
• Understanding Cu(I) binding supports the development of antibiotics and antimicrobials targeting copper resistance systems.
Molecular Mechanism of cuprous ion binding
Coordination chemistry of Cu(I)
In simple terms: Cu(I) is a soft copper ion that prefers sulfur and nitrogen atoms from amino acids.
Cuprous ion binding typically involves coordination by soft donor atoms such as cysteine sulfur, methionine sulfur, and histidine nitrogen. Because Cu(I) is a d10 ion, it does not have ligand-field stabilization preferences like Cu(II), allowing diverse geometries including linear, trigonal, and tetrahedral coordination. Structural studies of a dimeric periplasmic protein forming a six-helical bundle show how protein scaffolds can create specific Cu(I) binding sites. Calixarene-based model systems have also been used to probe Cu(I) binding within a tren cap, providing insights into the binding properties of embedded cuprous ions.
Cu(I) binding in multicopper proteins
In simple terms: Some proteins use several copper ions together to carry out oxidation reactions.
The green cupredoxin CopI is a multicopper protein able to oxidize Cu(I), demonstrating that Cu(I) binding is coupled to electron transfer and catalytic oxidation. Multicopper oxidases contain multiple copper centers that cycle between Cu(I) and Cu(II) during substrate oxidation. These proteins illustrate how Cu(I) binding sites are tuned for rapid electron transfer and metal oxidation, linking GO:1903136 to enzymatic function.
Cu(I) sensing and metalloregulation
In simple terms: Some proteins bind Cu(I) to sense copper levels and switch genes on or off.
The CsoR regulon of Streptomyces lividans provides a paradigm for Cu(I)-responsive gene regulation. Copper trafficking in this system involves Cu(I) binding by CsoR-family regulators, which controls expression of copper efflux and resistance genes. This shows that Cu(I) binding can act as a signal that reprograms transcription in response to copper availability.
Competitive Cu(I) binding in biochemical assays
In simple terms: In the BCA protein assay, proteins and BCA compete for the same cuprous ions.
The bicinchoninic acid (BCA) protein assay depends on the reduction of Cu(II) to Cu(I) and subsequent chelation of Cu(I) by BCA. Competitive binding to cuprous ions of protein and BCA influences the color yield, so the Cu(I) binding properties of sample components directly affect quantification. This principle is applied in protocols for samples prepared for two-dimensional electrophoresis, where accurate protein quantitation is critical.
Cu(I) transfer to cellular proteins
In simple terms: Copper can be handed from one molecule to another inside cells.
The cupric ion of the bleomycin copper complex can be reduced intracellularly, and the resulting cuprous ion is transferred to a cellular protein. This demonstrates that Cu(I) binding is not always static; it can involve metal transfer between ligands and proteins. Such transfer reactions are relevant to understanding how copper-containing drugs interact with cellular targets.
Key Genes Involved in GO:1903136 cuprous ion binding
The following genes and proteins are representative of cuprous ion binding (GO:1903136) based on the verified literature, including cupredoxins, multicopper oxidases, and copper-responsive regulators.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CopI | Green cupredoxin and multicopper protein able to oxidize Cu(I) | Model for Cu(I) oxidation and multicopper enzyme mechanism |
| CsoR | Cu(I)-responsive regulator in Streptomyces lividans | Paradigm for Cu(I)-sensing and copper efflux regulation |
| CopA | Copper efflux ATPase regulated by CsoR | Target for studying copper resistance and trafficking |
| CopZ | Copper chaperone involved in copper trafficking in the CsoR regulon | Model for intracellular Cu(I) transfer |
| CueO | Multicopper oxidase involved in copper homeostasis | Related to Cu(I) oxidation and detoxification |
| Sco1 | Copper chaperone for cytochrome c oxidase | Links Cu(I) binding to mitochondrial copper delivery |
| Cox17 | Copper chaperone delivering copper to mitochondria | Model for Cu(I) trafficking to cytochrome c oxidase |
| ATOX1 | Cytosolic copper chaperone | Relevant to Cu(I) delivery to copper-transporting ATPases |
| ATP7A | Copper-transporting ATPase | Disease-relevant Cu(I) transporter (Menkes disease) |
| ATP7B | Copper-transporting ATPase | Disease-relevant Cu(I) transporter (Wilson disease) |
| CCS | Copper chaperone for SOD1 | Links Cu(I) binding to antioxidant defense |
| SOD1 | Cu/Zn superoxide dismutase | Cu(I) binding relevant to antioxidant function and neurodegeneration |
| MT1A | Metallothionein | Cysteine-rich Cu(I) binding protein |
| MT2A | Metallothionein | Cysteine-rich Cu(I) binding protein |
| CTR1 | High-affinity copper uptake transporter | Controls Cu(I) entry into cells |
| DMT1 | Divalent metal transporter | Contributes to copper uptake and homeostasis |
| Bleomycin-binding protein | Cellular protein accepting Cu(I) from bleomycin copper complex | Model for metallodrug Cu(I) transfer |
How Is cuprous ion binding Regulated?
Cuprous ion binding is regulated at multiple levels. In bacteria, the CsoR regulon responds directly to Cu(I) availability: binding of Cu(I) by CsoR-family regulators controls expression of copper efflux and trafficking genes. In eukaryotes, copper homeostasis is maintained by transporters, chaperones, and metallothioneins that bind Cu(I) and prevent free copper toxicity. The BCA assay illustrates that Cu(I) binding can be competitive and influenced by the relative affinities of different ligands. Additionally, intracellular reduction of Cu(II) to Cu(I) can generate Cu(I) for transfer to proteins, as shown for the bleomycin copper complex. These mechanisms collectively regulate the availability and fate of Cu(I) within cells.
cuprous ion binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP7A | Menkes disease; impaired copper transport | Knockout or point-mutation cell models to study Cu(I) transport |
| ATP7B | Wilson disease; copper accumulation | Knock-in of patient mutations to assess Cu(I) handling |
| SOD1 | Amyotrophic lateral sclerosis; antioxidant defense | Overexpression or point-mutation models for Cu(I) binding |
| CsoR | Bacterial copper resistance | Knockout in Streptomyces lividans to test Cu(I) regulation |
| CopI | Copper oxidation and homeostasis | Overexpression and purification for Cu(I) oxidation assays |
Copper transport disorders
Mutations in copper-transporting ATPases ATP7A and ATP7B cause Menkes disease and Wilson disease, respectively, which are characterized by impaired copper distribution and Cu(I) handling. These disorders highlight the importance of Cu(I) binding and transfer in human health.
Neurodegeneration and oxidative stress
Cu(I) binding by SOD1 and copper chaperones is linked to antioxidant defense, and disruption of copper homeostasis has been associated with neurodegenerative processes. The redox activity of Cu(I) can contribute to oxidative stress when copper is mismanaged.
Metallodrug action
The bleomycin copper complex undergoes intracellular reduction to Cu(I), which is then transferred to a cellular protein, linking Cu(I) binding to the mechanism of this anticancer antibiotic. Understanding Cu(I) transfer may inform the design of copper-based therapeutics.
Bacterial copper resistance
The CsoR regulon controls copper resistance in Streptomyces lividans through Cu(I)-responsive regulation, and similar systems are relevant to bacterial survival in copper-rich environments. This has implications for antimicrobial strategies targeting copper resistance.
From cuprous ion binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene bind Cu(I) directly? | Point-mutation of predicted Cu(I)-coordinating residues (e.g., Cys, His, Met) followed by binding assays |
| Is a gene required for copper resistance? | Knockout of the gene in a copper-sensitive strain and growth assays with Cu(I) |
| Can a disease-associated mutation alter Cu(I) binding? | Knock-in of the patient mutation and comparison of Cu(I) binding affinity |
| Where does a Cu(I)-binding protein localize? | Tagged knock-in with fluorescent or affinity tag for imaging and proteomics |
| Does overexpression of a Cu(I)-binding protein alter copper homeostasis? | Overexpression cell lines and measurement of copper content and Cu(I) transfer |
| Can a Cu(I)-binding regulator control a target promoter? | Reporter gene assays with wild-type and mutant regulator |
How to Study the cuprous ion binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| BCA assay | Competitive Cu(I) binding between protein and BCA | Protein quantification and Cu(I) affinity comparisons |
| UV-Vis spectroscopy | Cu(I) coordination and redox state | Characterization of cupredoxins and multicopper proteins |
| X-ray crystallography | Three-dimensional structure of Cu(I) binding sites | Structural basis of Cu(I) recognition |
| NMR spectroscopy | Cu(I) binding-induced conformational changes | Solution studies of Cu(I) complexes and proteins |
| Transcriptional reporter assay | Cu(I)-dependent gene expression | Functional analysis of CsoR-family regulators |
| Radiolabeled copper transfer | Cu(I) transfer between ligands and proteins | Metallodrug mechanism studies |
| Site-directed mutagenesis | Role of specific residues in Cu(I) binding | Identification of coordinating amino acids |
| Isothermal titration calorimetry | Binding affinity and stoichiometry for Cu(I) | Quantitative Cu(I) binding studies |
Cu(I) binding assays
Direct measurement of Cu(I) binding can be performed using spectroscopic methods, competition assays, and calorimetry. The BCA assay is a classic example of competitive Cu(I) binding, where protein and BCA compete for cuprous ions. Such assays can be adapted to test the relative affinity of candidate proteins for Cu(I).
Structural biology
X-ray crystallography and NMR can reveal the coordination geometry of Cu(I) in proteins. Structural studies of a dimeric periplasmic protein forming a six-helical bundle have provided insights into Cu(I) binding sites. Model systems such as calixarene-tren caps have also been used to understand Cu(I) binding properties.
Transcriptional and genetic reporters
Cu(I)-responsive regulators such as CsoR can be studied using transcriptional reporters and gene expression analysis. In Streptomyces lividans, the CsoR regulon controls copper efflux genes, and reporter fusions can measure Cu(I)-dependent regulation.
Metal transfer and cellular assays
Cu(I) transfer from complexes to cellular proteins can be monitored using radiolabeled copper or fluorescent sensors. The transfer of Cu(I) from the bleomycin copper complex to a cellular protein has been demonstrated, providing a model for studying intracellular Cu(I) trafficking.
How CRISPR Can Be Used to Study GO:1903136 cuprous ion binding
Knockout
CRISPR knockout of genes encoding Cu(I)-binding proteins can reveal their contribution to copper homeostasis and resistance. For example, knocking out CsoR or its target genes in Streptomyces lividans would test the CsoR regulon's role in copper efflux. Knockout of eukaryotic copper chaperones or transporters can model copper transport disorders.
Point Mutation
Point mutations in predicted Cu(I)-coordinating residues (Cys, His, Met) can be introduced to test their role in Cu(I) binding. Such mutations in periplasmic Cu(I)-binding proteins or CsoR-family regulators can abolish or alter binding, as inferred from structural and functional studies.
Knock-in
Knock-in of disease-associated mutations in copper transporters such as ATP7A or ATP7B can model Menkes or Wilson disease and assess effects on Cu(I) handling. Knock-in of tagged versions of Cu(I)-binding proteins enables localization and interaction studies.
Overexpression
Overexpression of Cu(I)-binding proteins such as CopI or metallothioneins can be used to study copper oxidation, sequestration, and transfer. Overexpression models help determine whether increased Cu(I) binding capacity alters cellular copper sensitivity.
How EDITGENE Supports cuprous ion binding Research
Researchers studying cuprous ion binding-related genes often need to determine whether a candidate gene is causally involved in copper handling, resistance, or disease. EDITGENE provides CRISPR-based cell models and screening services to interrogate Cu(I) binding proteins with precision.
Contact EDITGENE today to design your custom CRISPR model for cuprous ion binding research.
Frequently Asked Questions About cuprous ion binding
What is cuprous ion binding?
Cuprous ion binding (GO:1903136) is the molecular function of binding to a cuprous ion, copper(1+), also known as Cu(I) binding.
What genes are involved in cuprous ion binding?
Genes encoding cupredoxins such as CopI, copper chaperones, copper-transporting ATPases, metallothioneins, and CsoR-family regulators are involved in cuprous ion binding.
What is the GO ID for cuprous ion binding?
The GO ID for cuprous ion binding is GO:1903136.
Why is cuprous ion binding important?
It is important for copper homeostasis, copper efflux regulation, electron transfer, and biochemical assays such as the BCA protein assay.
How is cuprous ion binding measured?
It can be measured by competitive binding assays like BCA, spectroscopy, structural biology, and metal transfer experiments.
What proteins bind Cu(I)?
Proteins that bind Cu(I) include cupredoxins, multicopper oxidases, copper chaperones, metallothioneins, and CsoR-family regulators.
What diseases are linked to copper binding?
Menkes disease and Wilson disease are linked to mutations in copper-transporting ATPases ATP7A and ATP7B, which handle Cu(I).
How does the BCA assay relate to cuprous ion binding?
The BCA assay relies on competitive binding of Cu(I) between protein and BCA, so Cu(I) binding properties affect the assay.
Can CRISPR be used to study cuprous ion binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to study genes involved in Cu(I) binding.
What is the CsoR regulon?
The CsoR regulon is a copper-responsive gene regulatory system in Streptomyces lividans that uses Cu(I) binding to control copper efflux genes.
Conclusion
GO:1903136 cuprous ion binding defines a fundamental molecular function that connects copper coordination chemistry to cellular copper homeostasis, metalloregulation, and biochemical assays. Proteins such as cupredoxins, copper chaperones, and CsoR-family regulators use Cu(I) binding to carry out electron transfer, metal trafficking, and gene regulation. Studying this function with CRISPR models and biochemical methods can reveal mechanisms of copper-related disease and inform therapeutic strategies.
References
- 1. Izzet G et al.. 2007. Insights into the binding properties of a cuprous ion embedded in the tren cap of a calixarene and supramolecular trapping of an intermediate.. Dalton Trans PMID: 17279248
- 2. Rossotti M et al.. 2024. The green cupredoxin CopI is a multicopper protein able to oxidize Cu(I).. J Inorg Biochem 254:112503 PMID: 38364337
- 3. Huang T et al.. 2010. Competitive Binding to Cuprous Ions of Protein and BCA in the Bicinchoninic Acid Protein Assay.. Open Biomed Eng J 4:271-8 PMID: 21625379
- 4. Yang J et al.. 2022. Structural basis of copper binding by a dimeric periplasmic protein forming a six-helical bundle.. J Inorg Biochem 229:111728 PMID: 35066349
- 5. Berkelman T. 2008. Quantitation of protein in samples prepared for 2-D electrophoresis.. Methods Mol Biol 424:43-9 PMID: 18369851
- 6. Takahashi K et al.. 1977. Intracellular reduction of the cupric ion of bleomycin copper complex and transfer of the cuprous ion to a cellular protein.. J Antibiot (Tokyo) 30(10):861-9 PMID: 73538
- 7. Prohaska JR. 2008. Role of copper transporters in copper homeostasis.. Am J Clin Nutr 88(3):826S-9S PMID: 18779302
- 8. Chaplin AK et al.. 2015. Copper trafficking in the CsoR regulon of Streptomyces lividans.. Metallomics 7(1):145-55 PMID: 25409712
